CONFIDENCE treatment success: long-term real-world effectiveness and safety of ocrelizumab in Germany

Research output: Contribution to journal › Research article › Contributed › peer-review

Contributors

  • Mathias Buttmann - , Caritas-Krankenhaus Bad Mergentheim (Author)
  • Martin S Weber - , University Medical Center Göttingen, Fraunhofer Institute for Translational Medicine and Pharmacology (Author)
  • Sven G Meuth - , University Hospital Duesseldorf (Author)
  • Sandra Blümich - , Roche Pharma AG (Author)
  • Stefanie Hieke-Schulz - , Roche Pharma AG (Author)
  • Petra Dirks - , F. Hoffmann-La Roche AG (Author)
  • Julius C Eggebrecht - , Roche Pharma AG (Author)
  • Tjalf Ziemssen - , Department of Neurology (Author)

Details

Original languageEnglish
Article number1564327
JournalFrontiers in neurology
Volume16
Publication statusPublished - 2025
Peer-reviewedYes

External IDs

PubMedCentral PMC12135804
Scopus 105007300019
ORCID /0000-0001-8799-8202/work/186184156

Keywords